Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 8

1.

Mood stabilizer psychopharmacology.

Gould TD, Chen G, Manji HK.

Clin Neurosci Res. 2002 Dec;2(3-4):193-212. Epub 2002 Nov 14.

2.

Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes.

Chen CH, Lin SK.

BMC Psychiatry. 2012 May 23;12:47. doi: 10.1186/1471-244X-12-47.

3.

Anticonvulsant drugs in bipolar disorder.

Grunze H, Schlösser S, Amann B, Walden J.

Dialogues Clin Neurosci. 1999 Jun;1(1):24-40.

4.

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.

Tamayo JM, Zarate CA Jr, Vieta E, Vázquez G, Tohen M.

Int J Neuropsychopharmacol. 2010 Jul;13(6):813-32. doi: 10.1017/S1461145709991246. Epub 2010 Feb 4. Review.

5.

Carbamazepine extended-release capsules in bipolar disorder.

Weisler RH.

Neuropsychiatr Dis Treat. 2006 Mar;2(1):3-11.

6.

Acute and long-term treatment of mania.

Vieta E, Sanchez-Moreno J.

Dialogues Clin Neurosci. 2008;10(2):165-79. Review.

7.

The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.

Dilsaver SC, Swann AC, Shoaib AM, Bowers TC.

J Psychiatry Neurosci. 1993 Mar;18(2):61-6. Review.

8.

The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

Simhandl C, Meszaros K.

J Psychiatry Neurosci. 1992 Mar;17(1):1-14. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk